(BUSINESS WIRE)--BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) today announced that Jon Stonehouse, President and Chief Executive Officer of BioCryst plans to provide a corporate summary and update regarding the Company’s clinical programs at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 13, 2011 at 8:00 a.m. Pacific Time.
